We conduct phase II, III and IV studies in the prevention and treatment of chronic diseases. Our three focus areas—obesity, diabetes and cardiovascular diseases—are at the forefront of clinical research and closely interrelated.
We also conduct research in other therapeutic areas, including pain, vaccines, memory disorders, nephrology, and dyslipidemia.
We are here to advance your therapeutic breakthroughs with extensive scientific and clinical experience, always adhering to Good Clinical Practice (GCP).
Contact usClinical trials are our core business and top priority—and we ensure they are always supported with dedicated, expert resources. Please see below for our ongoing and previous clinical trials.
A large international multicenter study of a novel weight loss medication for the prevention of cardiovascular disease in individuals with excess body weight and established cardiovascular disease
A large international multicenter study of a novel weight loss medication in individuals with excess body weight
A large international multicenter study of a novel inflammation-lowering medication on heart failure outcomes in individuals with heart failure and low-grade inflammation
A large international multicenter study of a novel weight loss medication in individuals with excess body weight and type 2 diabetes
A large international multicenter study of a novel weight loss medication in individuals with excess body weight but without diabetes
A large international multicenter study of a novel cholesterol-lowering medication for the prevention of cardiovascular events in individuals with established cardiovascular disease
A large international multicenter study of two weight loss medications in individuals with excess body weight
A large international multicenter study of a weight loss medication and long-acting insulin on glucose management in individuals with type 2 diabetes
A large international multicenter study of a novel anticoagulant for the prevention of stroke in individuals with atrial fibrillation
A large international multicenter study of a weight loss medication on the incidence of cardiovascular disease in individuals with excess body weight but without diabetes
A large international multicenter study of a novel cholesterol-lowering medication on the incidence of cardiovascular disease in individuals at elevated risk
A large international multicenter study of a cholesterol-lowering medication on the incidence of cardiovascular disease in individuals at elevated risk